Page last updated: 2024-11-13

scutebarbatine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

scutebarbatine A: has antineoplastic activity; isolated from Scutellaria barbata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
ScutellariagenusA plant genus of the family Lamiaceae used in folk medicine.[MeSH]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]

Cross-References

ID SourceID
PubMed CID45110781
CHEMBL ID3577094
MeSH IDM000602778

Synonyms (9)

Synonym
scutebarbatine a
176520-13-1
CHEMBL3577094
AKOS037515187
[(1r,2s,3r,4r,4as,8ar)-3-hydroxy-3,4,8,8a-tetramethyl-4-[(e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-2-(pyridine-3-carbonyloxy)-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl] pyridine-3-carboxylate
(-)-scutebarbatine a
CS-0016664
HY-N1260
FS-10489

Research Excerpts

Overview

Scutebarbatine A is a new neo-Clerodane Diterpenoid Alkaloids from Scutellaria barbata. It has many pharmacological effects, such as anti-tumor, antibacterial, and anti-inflammatory.

ExcerptReferenceRelevance
"Scutebarbatine A is a new neo-Clerodane Diterpenoid Alkaloids from Scutellaria barbata, which has many pharmacological effects, such as anti-tumor, antibacterial, and anti-inflammatory. "( Identification of the Metabolites of Scutebarbatine A in Rat Plasma, Bile, Urine, and feces by Using Ultra-high-performance Liquid Chromatography Coupled with Q Exactive Hybrid Quadrupole-orbitrap High-resolution Mass Spectrometry.
Gao, J; Sun, L; Wang, H; Yang, G; Yuan, N; Zhao, L, 2022
)
2.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1318675Cytotoxicity against human MCF7 cells assessed as inhibition of cell survival rate at 50 uM after 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Oct-04, Volume: 121neo-Clerodane diterpenoids from Scutellaria barbata mediated inhibition of P-glycoprotein in MCF-7/ADR cells.
AID1225463Antiviral activity against EBV infected in TPA and sodium butyrate-induced P3HR1 cells assessed as inhibition on EBV lytic replication at 20 uM incubated for 48 hrs by SYBR green dye based real-time PCR method2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Neo-clerodane diterpenoids from Scutellaria barbata with activity against Epstein-Barr virus lytic replication.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.04 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]